title: Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
abstract: CD4, a lymphocyte surface glycoprotein, serves as co-receptor for antigen with the T cell receptor (TCR). It is also the lymphocyte receptor for HIV by binding the gp120 viral envelope protein. Interaction of gp120 with CD4 is crucial for viral infection, but is not sufficient to allow viral entry into cells. Recombinant gp120 alters CD4+ T cell responsiveness to activation stimuli. To express its co-receptor function fully, CD4 must be laterally associated with the TCR and CD45 to form multi-receptor complexes competent to transduce potent activation signals. Here, we examine the possibility that gp120/CD4 binding alters lateral associations of CD4 with other lymphocyte surface molecules, and that assembly of abnormal multi-molecular complexes is involved in the gp120-induced CD4+ T cell dysfunction and in viral entry. In the absence of gp120, CD4 displayed high association with CD3, CD5, CD45RC, CD25, CD28, CD44, and CD53; weak association with CD2, CD38, CD45RB, CD62L, and CD26; and no association with CD45RA, CD45RO, CD11b, CD11a, CD54, CD7, CD48, CD98, CD59 CD55, HLA class I and class II molecules. Treatment with gp120 significantly increased CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreased that with CD45RC. Specificity of these results were assessed at various levels. First, gp120 did not influence lateral associations displayed by other molecules, such as HLA class II. Second, the Leu3 mAb which binds CD4 on a site overlapping the gp120 binding site, did not elicit the same CD4 lateral associations as gp120, and finally, a direct gp120/CD4+ interaction was needed to induce the lateral associations, as shown by the observation that blocking the gp120/CD4 binding by the Leu3 mAb inhibited the gp120-induced associations. These results can be interpreted in several ways gp120/CD4 interaction could trigger an inside-out signal responsible for the associations, or gp120 could induce steric modifications of CD4 that increase its affinity for the associating molecules. Alternatively, these molecules may interact directly with gp120, bridging them with CD4. It is also possible that th e associations may be mediated by additional components, interacting with both gp120 and the associating surface molecule. The last hypothesis is likely for CD59, whose gp120-induced association with CD4 required the presence of serum in the co-capping assay. Since both CD59 and gp120 bind complement, the observed association could be mediated by complement components.
authors.affiliation: Dipartimento di Scienze Mediche, Università di Torino, Italy.
authors.forename: U
authors.initials: U
authors.lastname: Dianzani
authors.forename: M
authors.initials: M
authors.lastname: Bragardo
authors.forename: D
authors.initials: D
authors.lastname: Buonfiglio
authors.forename: V
authors.initials: V
authors.lastname: Redoglia
authors.forename: A
authors.initials: A
authors.lastname: Funaro
authors.forename: P
authors.initials: P
authors.lastname: Portoles
authors.forename: J
authors.initials: J
authors.lastname: Rojo
authors.forename: F
authors.initials: F
authors.lastname: Malavasi
authors.forename: A
authors.initials: A
authors.lastname: Pileri
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism*; D000954:Antigens, Surface / Q000378:metabolism*; D015704:CD4 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018957:CD59 Antigens; D003165:Complement System Proteins / Q000502:physiology; D016895:Culture Media, Serum-Free; D018819:Dipeptidyl Peptidase 4 / Q000502:physiology; D015699:HIV Envelope Protein gp120 / Q000378:metabolism / Q000494:pharmacology*; D015497:HIV-1 / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007152:Immunologic Capping / Q000187:drug effects*; D017493:Leukocyte Common Antigens / Q000276:immunology / Q000378:metabolism*; D008213:Lymphocyte Activation; D046911:Macromolecular Substances; D008562:Membrane Glycoproteins / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology / Q000378:metabolism*; D015398:Signal Transduction; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000954:Antigens, Surface; D015704:CD4 Antigens; D018957:CD59 Antigens; D016895:Culture Media, Serum-Free; D015699:HIV Envelope Protein gp120; D006680:HLA Antigens; D046911:Macromolecular Substances; D008562:Membrane Glycoproteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D003165:Complement System Proteins; D017493:Leukocyte Common Antigens; D018819:Dipeptidyl Peptidase 4